Bioorganic and Medicinal Chemistry Letters p. 127 - 132 (1999)
Update date:2022-08-05
Topics:
Reiter, Lawrence A.
Rizzi, James P.
Pandit, Jayvardan
Lasut, Michael J.
McGahee, Shunda M.
Parikh, Vinod D.
Blake, James F.
Danley, Dennis E.
Laird, Ellen R.
Lopez-Anaya, Arturo
Lopresti-Morrow, Lori L.
Mansour, Mahmoud N.
Martinelli, Gary J.
Mitchell, Peter G.
Owens, Brian S.
Pauly, Thomas A.
Reeves, Lisa M.
Schulte, Gayle K.
Yocum, Sue A.
Through the use of empirical and computational methods, phosphinate- based inhibitors of MMP-1 and MMP-13 that bind into the S2 pocket of these enzymes were designed. The synthesis and testing of 2 suggested that binding was occuring as hypothesized. Structure determination of a co-crystal of 2 bound to the catalytic domain of MMP-1 confirmed the binding mode. Substituents binding into S2, S1', S2' and S3', were optimized yielding compounds with low double-digit nM IC50's against these enzymes.
View MoreContact:86-571-61063068
Address:LINAN
Nanjing lanbai chemical Co.,Ltd.
Contact:+86-25-85499326
Address:Room 908, 9F Taiyue Building,No.285 Heyan Road
Sichuan Highlight Fine Chemicals Co., Ltd.
Contact:+86-28-8525 1605
Address:A5-102 Airport base,388 West Airport Huang He Zhong Lu,2 Section
qingdao goldenchem imp and exp co.,ltd.
Contact:532-55579246
Address:no.62 ,haier road laoshan distirct
Nanjing distinctions Medical Technology Co., Ltd.(expird)
Contact:+86-15996203785 13914714059
Address:nanjing,jiangsu , China
Doi:10.1021/om401184n
(2014)Doi:10.1016/S0031-9422(00)00473-8
(2001)Doi:10.1002/chem.201403161
(2014)Doi:10.1016/j.catcom.2013.12.012
(2014)Doi:10.1248/cpb.42.739
(1994)Doi:10.1016/S0040-4039(00)61549-6
(1993)